SCHEMBL8525009

SCHEMBL8525009

Cc1ccc(-c2cc(C(F)F)nn2-c2ccccc2S(N)(=O)=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.65
PTGS1 P23219 10/20 0.65
CYP2C9 P11712 2/20 0.45
ABCB11 O95342 2/20 0.44
ALDH1A1 P00352 1/20 0.44
PDPK1 O15530 2/20 0.43
PTGES O14684 1/20 0.43
HDAC3 O15379 1/20 0.43
CA12 O43570 1/20 0.43
PDE5A O76074 1/20 0.43
MT-CO2 P00403 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
LMNA P02545 1/20 0.43
CA3 P07451 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX5 P09917 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CYP2D6 P10635 1/20 0.43
ADRB3 P13945 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8165901 0.98 PTGS2 (0.62) PTGS2PTGS1CYP2C9ABCB11ALDH1A1
Benzenesulfonamide SCHEMBL8625195 0.95 PTGS2 (0.68) PTGS2PTGS1CYP2C9ABCB11ALDH1A1
SCHEMBL8637047 0.91 PTGS2 (0.63) PTGS2PTGS1ABCB11ALDH1A1PDPK1
SCHEMBL7928751 0.90 PTGS2 (0.66) PTGS2PTGS1ABCB11ALDH1A1PDPK1
SCHEMBL8635925 0.89 PTGS2 (0.58) PTGS2PTGS1ABCB11ALDH1A1
SCHEMBL8688704 0.89 PTGS2 (0.51) PTGS2PTGS1ABCB11ALDH1A1
SCHEMBL7773921 0.88 PTGS2 (0.65) PTGS2PTGS1ABCB11ALDH1A1PDPK1
SCHEMBL8625458 0.88 PTGS2 (0.67) PTGS2PTGS1ABCB11ALDH1A1
SCHEMBL8639101 0.88 PTGS2 (0.52) PTGS2PTGS1ABCB11ALDH1A1
SCHEMBL8639180 0.86 PTGS2 (0.53) PTGS2PTGS1CYP2C9ABCB11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760068-A NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G.D. SEARLE & CO. (US) 1998-06-02 US claimed
EP-0941080-A2 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS G.D. SEARLE & CO. (US) 1999-09-15 EP disclosed
US-5760068-A NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G.D. SEARLE & CO. (US) 1998-06-02 US disclosed
WO-1998022101-A2 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS G.D. SEARLE & CO. (US) 1998-05-28 WO disclosed
US-5756529-A ANTIINFLAMMATORY G.D. SEARLE & CO. (US) 1998-05-26 US disclosed